• 1
    Riggs BL, Melton LJ III 1986 Involutional osteoporosis. N Engl J Med 314:16761686.
  • 2
    Lindsay R, Aitken JM, Anderson JB, Hart DM, McDonald EB, Clarke AC 1976 Long-term prevention of postmenopausal osteoporosis by estrogen. Evidence for an increased bone mass after delayed onset of estrogen treatment. Lancet 1:10381041.
  • 3
    Kiel DP, Felson DT, Anderson JJ, Wilson PWF, Moskowitz MA 1987 Hip fracture and the use of estrogens in postmenopausal women. N Engl J Med 317:11691174.
  • 4
    Cauley JA, Seeley DG, Ensrud K, Ettinger B, Black DM, Cummings SR 1995 Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group. Ann Int Med 122:916.
  • 5
    Armamento-Villareal R, Villareal DT, Avioli LV, Civitelli R 1992 Estrogen status and heredity are major determinants of premenopausal bone mass. J Clin Invest 90:24642471.
  • 6
    Nguyen TV, Jones G, Sambrook PN, White CP, Kelly PJ, Eisman JA 1995 Effects of estrogen exposure and reproductive factors on bone mineral density and osteoporotic fractures. J Clin Endocrinol Metab 80:27092714.
  • 7
    Nordin BEC, Need AG, Chatterton BE, Horowitz M, Morris HA 1990 The relative contributions of age and years since menopause to postmenopausal bone loss. J Clin Endocrinol Metab 70:8388.
  • 8
    Pouilles JM, Tremollieres F, Ribot CA 1993 The effect of menopause on longitudinal bone loss from the spine. Calcif Tissue Int 52:340343.
  • 9
    Walkinshaw MH, Mole PA, Paterson CR 1992 Potential value of urinary oestrogen assays in the identification of fast bone losers after the menopause. Osteoporos Int 2:205209.
  • 10
    Davidson BH, Ross RK, Paganini-Hill A, Hammond GD, Siiteri PK, Judd HL 1982 Total and free estrogens and androgens in postmenopausal women with hip fractures. J Clin Endocrinol Metab 54:115120.
  • 11
    Slemenda CW, Hui SL, Longcope C, Johnston CC Jr 1987 Sex steroids and bone mass. A study of changes about the time of menopause. J Clin Invest 80:12611269.
  • 12
    Van Beresteijn ECH, Van Laarhoven JPRM, Smals AGH 1992 Body weight and/or endogenous estradiol as determinants of cortical bone mass and bone loss in healthy early postmenopausal women. Acta Endocrinol 127:226230.
  • 13
    Barrett-Connor E, Mueller JE, von Muhlen DG, Laughlin GA, Schneider DL, Sartoris DJ 2000 Low levels of estradiol are associated with vertebral fractures in older men, but not women: The Rancho Bernardo Study. J Clin Endocrinol Metab 85:219223.
  • 14
    Cummings SR, Browner WS, Bauer D, Stone K, Ensrud K, Jamal S, Ettinger B 1998 Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group. N Engl J Med 339:733738.
  • 15
    Khosla S, Melton LJ III, Atkinson EJ, O'Fallon WM, Klee GG, Riggs BL 1998 Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: A key role for bioavailable estrogen. J Clin Endocrinol Metab 83:22662274.
  • 16
    Longcope C, Kato T, Horton R 1969 Conversion of blood androgens to estrogens in normal adult men and women. J Clin Invest 48:21912201.
  • 17
    Grodin JM, Siiteri PK, MacDonald PC 1973 Source of estrogen production in postmenopausal women. J Clin Endocrinol Metab 36:207214.
  • 18
    Forney JP, Milewich L, Chen GT, Garlock JL, Schwarz BE, Edman CD, MacDonald PC 1981 Aromatization of androstenedione to estrone by human adipose tissue in vitro. Correlation with adipose tissue mass, age, and endometrial neoplasia. J Clin Endocrinol Metab 53:192199.
  • 19
    Nawata H, Tanaka S, Takayanagi R, Sakai Y, Yanase T, Ikuyama S, Haji M 1995 Aromatase in bone cell: Association with osteoporosis in postmenopausal women. J Steroid Biochem Mol Biol 53:165174.
  • 20
    Fishman J, Bradlow HL, Gallagher TF 1960 Oxidative metabolism of estradiol. J Biol Chem 235:31043107.
  • 21
    Adlercreutz H, Gorbach SL, Goldin BR, Woods MN, Dwyer JT, Hamalainen E 1994 Estrogen metabolism and excretion in Oriental and Caucasian women. J Natl Cancer Inst 86:10761082.
  • 22
    Fishman J, Martucci C 1980 Biological properties of 16α-hydroxyestrone: Implications in estrogen physiology and pathophysiology. J Clin Endocrinol Metab 51:611615.
  • 23
    Martucci C, Fishman J 1977 Direction of estradiol metabolism as a control of its hormonal action-uterotropic activity of estradiol metabolites. Endocrinology 101:17091715.
  • 24
    Michnovicz JJ, Bradlow HL 1990 Dietary and pharmacological control of estradiol metabolism in humans. Ann NY Acad Sci 595:291299.
  • 25
    Michnovicz JJ, Hershcopf RJ, Naganuma H, Bradlow HL, Fishman J 1986 Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. N Engl J Med 315:13051309.
  • 26
    Michnovicz JJ, Naganuma H, Hershcopf RJ, Bradlow HL, Fishman J 1988 Increased urinary catechol estrogen excretion in female smokers. Steroids 52:6983.
  • 27
    Michnovicz JJ, Galbraith RA 1991 Cimetidine inhibits catechol estrogen metabolism in women. Metabolism 40:170174.
  • 28
    Lim SK, Won YJ, Lee JH, Kwon SH, Lee EJ, Kim KR, Lee HC, Huh KB, Chung BC 1997 Altered hydroxylation of estrogen in patients with postmenopausal osteopenia. J Clin Endocrinol Metab 82:10011006.
  • 29
    Adlercreutz H, Fotsis T 1998 Comment on altered hydroxylation of estrogen in patients with postmenopausal osteopenia. J Clin Endocrinol Metab 83:41704171.
  • 30
    Westerlind KC, Gibson KJ, Malone P, Turner RT 1998 Differential effects of estrogen metabolites on bone and reproductive tissues of ovariectomized rats. J Bone Miner Res 13:10231031.
  • 31
    Armamento-Villareal R, Civitelli R 1995 Estrogen action on bone mass of postmenopausal women is dependent on body mass and initial bone density. J Clin Endocrinol Metab 80:776782.
  • 32
    Michnovicz JJ, Adlercreutz H, Bradlow HL 1997 Changes in levels of urinary estrogen metabolites after oral indole-3-carbinol treatment in humans. J Natl Cancer Inst 89:718723.
  • 33
    Klug TL, Bradlow HL, Sepkovic DW 1994 Monoclonal antibody-based enzyme immunoassay for simultaneous quantitation of 2- and 16 alpha-hydroxyestrone in urine. Steroids 59:648655.
  • 34
    Looker AC, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP, Johnston CC Jr, Lindsay R 1998 Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 8:468489.
  • 35
    De Simone DP, Stevens J, Edwards J, Shary J, Gordon L, Bell NH 1989 Influence of body habitus and race on bone mineral density of the midradius, hip, and spine in aging women. J Bone Miner Res 4:827830.
  • 36
    Harris S, Dallal GE, Dawson-Hughes B 1992 Influence of body weight on rates of change in bone density of the spine, hip, and radius in postmenopausal women. Calcif Tissue Int 50:1923.
  • 37
    Snow RC, Barbieri RL, Frisch RE 1989 Estrogen 2-hydroxylase oxidation and menstrual function among elite oarswomen. J Clin Endocrinol Metab 69:369376.
  • 38
    Frisch RE, Snow RC, Johnson LA, Gerard B, Barbieri R, Rosen B 1993 Magnetic resonance imaging of overall and regional body fat, estrogen metabolism, and ovulation of athletes compared to controls. J Clin Endocrinol Metab 77:471477.
  • 39
    Lou YC 1990 Differences in drug metabolism polymorphism between Orientals and Caucasians. Drug Metab Rev 22:451475.
  • 40
    Cauley JA, Lucas FL, Kuller LH, Vogt MT, Browner WS, Cummings SR 1996 Bone mineral density and risk of breast cancer in older women: The study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group. JAMA 276:14041408.
  • 41
    Kabat GC, Chang CJ, Sparano JA, Sepkovie DW, Hu XP, Khalil A, Rosenblatt R, Bradlow HL 1997 Urinary estrogen metabolites and breast cancer: A case-control study. Cancer Epidemiol Biomarkers Prev 6:505509.
  • 42
    Schneider J, Huh MM, Bradlow HL, Fishman J 1984 Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells. J Biol Chem 259:48404845.
  • 43
    Vandewalle B, Lefebvre J 1989 Opposite effects of estrogen and catecholestrogen on hormone-sensitive breast cancer cell growth and differentiation. Mol Cell Endocrinol 61:239246.
  • 44
    Loukovaara M, Carson M, Adlercreutz H 1995 Regulation of sex-hormone-binding globulin production by endogenous estrogens in vitro. Biochem Biophys Res Commun 206:895901.
  • 45
    Yang NN, Venugopalan M, Hardikar S, Galsebrook A 1996 Identification of an estrogen response element activated by metabolites of 17β-estradiol and raloxifene. Science 273:12221225.
  • 46
    Russell JB, Mitchell D, Musey PI, Collins DC 1984 The relationship of exercise to anovulatory cycles in female athletes: Hormonal and physical characteristics. Obstet Gynecol 63:452456.
  • 47
    Schinfeld JS, Tulchinsky D, Schiff I, Fishman J 1980 Suppression of prolactin and gonadotropin secretion in post-menopausal women by 2-hydroxyestrone. J Clin Endocrinol Metab 50:408410.
  • 48
    Shou M, Korzekwa KR, Brooks EN, Krausz KW, Gonzalez FJ, Gelboin HV 1997 Role of human hepatic cytochrome P450 1A2 and 3A4 in the metabolic activation of estrone. Carcinogenesis 18:207214.